Inhibrx Biosciences Ownership | Who Owns Inhibrx Biosciences?


OverviewForecastRevenueFinancialsChart

Inhibrx Biosciences Ownership Summary


Inhibrx Biosciences is owned by 67.46% institutional investors, 27.19% insiders, and 5.35% retail investors. Viking global investors lp is the largest institutional shareholder, holding 11.56% of INBX shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.32% of its assets in Inhibrx Biosciences shares.

INBX Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockInhibrx Biosciences67.46%27.19%5.35%
SectorHealthcare Stocks 488.17%11.08%-399.26%
IndustryBiotech Stocks 306.59%11.10%-217.69%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Viking global investors lp1.79M11.56%$25.51M
Sanofi1.16M7.49%$16.52M
Perceptive advisors977.89K6.32%$13.95M
Blackrock funding, inc. /de728.74K4.71%$10.40M
Sofinnova investments708.68K4.58%$10.11M
Millennium management255.34K1.76%$3.57M
Pfm health sciences, lp244.26K1.58%$3.49M
Caption management199.51K1.29%$2.85M
Kennedy capital management177.32K1.15%$2.53M
Acadian asset management120.12K0.78%$1.71M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Sanofi1.16M9.40%$16.52M
Sofinnova investments708.68K0.62%$10.11M
Perceptive advisors977.89K0.52%$13.95M
Birchview capital, lp32.11K0.46%$458.21K
Pfm health sciences, lp244.26K0.30%$3.49M
Arbiter partners capital management19.76K0.25%$281.96K
Murchinson33.79K0.17%$482.18K
Ikarian capital42.12K0.12%$601.08K
Yakira capital management21.12K0.10%$301.35K
Viking global investors lp1.79M0.07%$25.51M

Top Buyers

HolderShares% AssetsChange
Wetherby asset management40.66K0.03%40.66K
Readystate asset management lp26.83K0.01%26.83K
Hrt financial lp19.78K0.00%19.78K
Mark asset management lp17.00K0.02%17.00K
Ethic15.74K0.00%15.74K

Top Sellers

HolderShares% AssetsChange
Blackrock---2.75M
Ra capital management---2.63M
State street---2.42M
Vanguard group---1.86M
Tcg crossover management---1.75M

New Positions

HolderShares% AssetsChangeValue
Wetherby asset management40.66K0.03%40.66K$580.16K
Readystate asset management lp26.83K0.01%26.83K$382.92K
Hrt financial lp19.78K0.00%19.78K$282.00K
Mark asset management lp17.00K0.02%17.00K$243.00K
Ethic15.74K0.00%15.74K$227.11K

Sold Out

HolderChange
Quest partners-1.00
Financial gravity asset management-2.00
Jones financial companies lllp-4.00
Ifp advisors-4.00
Us bancorp \de\-16.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 202586-10.42%10,434,307-3.62%671.38%303.45%34-5.56%
Mar 31, 20259-91.59%2,655,100-76.21%180.35%2-95.74%2-93.55%
Dec 31, 20241072.88%11,162,06025.45%722.18%47-20.34%3172.22%
Sep 30, 202410410.64%8,897,409-8.12%571.29%59118.52%18-70.49%
Jun 30, 20242-98.47%33,090-99.91%-0.00%--100.00%1-97.37%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv1.22M2.32%94.03K
Vanguard Institutional Extnd Mkt Idx Tr394.10K0.75%-76.00
The Merger Fund A198.51K0.38%198.51K
Vanguard Russell 2000 ETF129.24K0.25%1.43K
Meridian Small Cap Growth Legacy123.63K0.24%-39.95K
ArrowMark Small Cap Gro123.63K0.24%-39.95K
NT R2000 Index Fund - NL95.63K0.18%-1.93K
NT R2000 Index Fund - DC - NL - 275.94K0.14%-886.00
NT R2000 Growth Index Fund - NL65.89K0.13%-2.36K
iShares Russell 2000 Small-Cap Idx Instl64.02K0.12%-

Recent Insider Transactions


DateNameRoleActivityValue
Nov 19, 2024Kayyem Jon Faiz-Buy$495.71K
Nov 20, 2024Kayyem Jon Faiz-Buy$266.10K
Oct 03, 2024Vuori Kristiina MD-Buy$100.00K
Sep 12, 2024Lappe Mark Chief Executive OfficerBuy$405.79K
Sep 16, 2024Lappe Mark Chief Executive OfficerBuy$223.32K

Insider Transactions Trends


DateBuySell
2025 Q2--
2025 Q1--
2024 Q43-
2024 Q37-
2024 Q2-1

INBX Ownership FAQ


Who Owns Inhibrx Biosciences?

Inhibrx Biosciences shareholders are primarily institutional investors at 67.46%, followed by 27.19% insiders and 5.35% retail investors. The average institutional ownership in Inhibrx Biosciences's industry, Biotech Stocks , is 306.59%, which Inhibrx Biosciences falls below.

Who owns the most shares of Inhibrx Biosciences?

Inhibrx Biosciences’s largest shareholders are Viking global investors lp (1.79M shares, 11.56%), Sanofi (1.16M shares, 7.49%), and Perceptive advisors (977.89K shares, 6.32%). Together, they hold 25.37% of Inhibrx Biosciences’s total shares outstanding.

Does Blackrock own Inhibrx Biosciences?

BlackRock is not among the top 10 institutional shareholders of Inhibrx Biosciences.

Who is Inhibrx Biosciences’s biggest shareholder by percentage of total assets invested?

Sanofi is Inhibrx Biosciences’s biggest shareholder by percentage of total assets invested, with 9.40% of its assets in 1.16M Inhibrx Biosciences shares, valued at 16.52M$.

Who is the top mutual fund holder of Inhibrx Biosciences shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Inhibrx Biosciences shares, with 2.32% of its total shares outstanding invested in 1.22M Inhibrx Biosciences shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools